MPX International (CSE:MPXI;OTC:MPXOF) announced Monday (July 29) that its subsidiary, Canveda, has received approval from Health Canada to sell fresh and dried cannabis.
As quoted in the press release:
“The ability to sell into both the recreational and medical cannabis markets in Canada as a result of this amendment represents a significant milestone for Canveda and opens the door to significant growth opportunities that we are ready to capitalize on,” said W. Scott Boyes, Chairman, President and CEO of MPX International. “On the recreational side, we will be able to apply to provincial boards to provide fresh and dried cannabis directly into a high demand market that has been limited by supply constraints. On the medical side, we have a comprehensive growth strategy with all of the required elements in place so that we may begin to immediately execute on our plan to drive patient acquisition, revenue growth and shareholder value.”